Bioventure and AJA Pharma Sign MoU Leveraging Existing Strategic Partnership

UAE, January 31, 2023 – Bioventure FZ-LLC, a pharmaceutical company with a global network focused on the investment and licensing of diverse pharmaceutical products and a subsidiary of? Yas Holding Healthcare ?and? AJA Pharma , a subsidiary of? Saudi Chemical Company Holding ?(SCCH) signed a Memorandum of Understanding (MoU) today to strengthen the existing strategic partnership between the two institutions.

The collaboration will focus on diabetes, oncology and biosimilars, therapeutic categories that are forecasted to be among the largest and fastest-growing within the global pharma sector over the coming years.

The extension of the long-standing strategic partnership between Bioventure and AJA involves a variety of delivery forms, including complex to develop formulations.

Bioventure continues to strengthen its position in the region, providing the healthcare community and their patients with high-quality, accessible and affordable treatment.

Commenting on the agreement,?Eng. Thamer Al-Muhid, GCEO of SCCH and MD, said:

“(SCCH) aspires to develop its manufacturing arm in the pharma sector, AJA Pharma, through such investment which will contribute to strengthening its position as a Saudi Pharmaceutical manufacturer in the field of Oncology, Diabetes and Specialty products, to serve and meet community needs.”

Also,? Ashraf Radwan , CEO of GlobalOne Healthcare, said:

Bioventure is committed to improving access to quality healthcare for patients in the Middle East, and this MoU with AJA Pharma marks a significant step towards achieving that goal. By expanding our licensing and supply capabilities, we can bring a wider range of innovative, effective treatments to the people who need them most. I am thrilled to be working with AJA Pharma to bring these solutions to patients in the Middle East and make a meaningful difference in their lives”.

About AJA Pharmaceutical Industries

Founded in 1972, AJA Pharmaceutical Industries is a subsidiary of the well-known Saudi Chemical Company Holding (SCCH). With its own state-of-the-art manufacturing plant, AJA commits to providing the latest and highest standards of manufacturing services across the region.

The company’s goal is to contribute value to Arab Healthcare and become the partner of choice for other scientifically based manufacturers. In this way, they also add value to customers and the whole community.

About Bioventure

Established as the investment arm of GlobalOne Healthcare Holding, Bioventure aims to support innovation, business development and global reach of value-added healthcare solutions.

The company’s three-strand approach includes out-licensing, investment, and increased market access. Bioventure helps pharmaceutical companies license biosimilars and innovative new products and expands market presence and manufacturing capability.

Visit Yas Holding's website for more information or you can contact:

Bahaa Rashad

Sr. Director-Pricing, Market Access and Tenders

?? [email protected]

?? +971502783120

Shreya Jain

Scientific Office Manager

?? [email protected]

?? +971 (56) 5377166